Table 1.
Clinical and imaging characteristics of patients with glioblastomas with and without FGFR3-TACC3 fusions
| FGFR3-TACC3 fusion | P | ||
|---|---|---|---|
| Present (n = 37) | Absent (n = 867) | ||
| Age | 0.02 | ||
| Mean (IQR) | 63.6 (57.2–72.2) | 59.4 (52.0–68.1) | |
| Sex | 1.00 | ||
| Male | 22 (59.5%) | 524 (60.4%) | |
| Female | 15 (40.5%) | 343 (39.6%) | |
| Ethnicity | 0.32 | ||
| White | 33 (89.2%) | 718 (89.0%) | |
| Black | 3 (8.1%) | 26 (3.2%) | |
| Asian | 1 (2.7%) | 56 (6.9%) | |
| Hispanic | 0 (0%) | 7 (0.9%) | |
| Unavailable | 0 | 60 | |
| Laterality | 0.72 | ||
| Left | 14 (45.2%) | 313 (49.1%) | |
| Right | 17 (54.8%) | 325 (50.9%) | |
| Unavailable | 6 | 229 | |
| Location | 0.68 | ||
| Frontal | 13 (35.1%) | 222 (33.9%) | |
| Temporal | 11 (29.7%) | 196 (30.0%) | |
| Parietal | 9 (24.3%) | 153 (23.4%) | |
| Occipital | 2 (5.4%) | 41 (6.3%) | |
| Callosal | 2 (5.4%) | 12 (1.8%) | |
| Cerebellar | 0 (0%) | 4 (0.6%) | |
| Other | 0 (0%) | 26 (4.0%) | |
| Unavailable | 0 | 213 | |